Highlights
A collection of news and information related to Human Genome Sciences Inc. published by this site and its partners.
Displaying items 1-12 of 18
» View wsbt.com items only
1
2
•
Next >
-
Bioterrorism consultant's anthrax claims challenged
WASHINGTON — As an example of the ease with which terrorists could produce anthrax, former Navy Secretary Richard J. Danzig has repeatedly cited the Japanese cult Aum Shinrikyo. The cult gained infamy in 1995 by unleashing the nerve agent sarin in...Tags: University of Maryland, College Park, U.S. Department of Homeland Security, Unrest, Conflicts and War, Science and Technology, George W. Bush
-
Pointing to threat, pulling in profit
Tribune Washington BureauWASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...Tags: U.S. Centers for Disease Control and Prevention, Crime, Law and Justice, George W. Bush, Food and Drug Administration, Bioterrorism
-
Timeline: An attorney and anthrax
May 2001: Washington lawyer Richard J. Danzig is appointed to the board of Human Genome Sciences Inc. in Rockville, Md. Sept. 11, 2001: Terrorists crash passenger jets into the World Trade Center in New York, the Pentagon and rural Pennsylvania. Soon...Tags: U.S. Congress, Rockville (Bethlehem, Pennsylvania), GlaxoSmithKline PLC, Anthrax
-
Spotlighting a terrorism risk, and profiting
WASHINGTON — Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he...
Tags: U.S. Centers for Disease Control and Prevention, Crime, Law and Justice, George W. Bush, Food and Drug Administration, White House
-
Human Genome to lay off 97 workers
Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...Tags: Layoffs and Downsizing, Unemployment, Rockville (Bethlehem, Pennsylvania), GlaxoSmithKline PLC, Career and Workplace
-
Human Genome Sciences announces plan to lay off 114
Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...Tags: Layoffs and Downsizing, Unemployment, Rockville (Bethlehem, Pennsylvania), GlaxoSmithKline PLC, Career and Workplace
-
GlaxoSmithKline to acquire Human Genome Sciences
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...Tags: Amylin Pharmaceuticals Incorporated, Biotechnology, Bristol Myers Squibb Company, AstraZeneca Plc, Food and Drug Administration
-
GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
Tags: Criminals, Crime, Law and Justice, U.S. Department of Justice, Avandia (drug), Chemical Industry
-
Ripley's opens Odditorium at Harborplace
Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion. Ripley Entertainment Inc. said exhibits at the Inner Harbor...Tags: Biotechnology, Media Industry, Crime, Law and Justice, Financially Distressed Companies, Inner Harbor
-
Consolidation wave poised to hit state's health care services, biopharma sectors
Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...Tags: Layoffs and Downsizing, Biotechnology, Stock Market, HealthSpring Inc., AstraZeneca Plc
-
Uncertain year ahead for U.S. stocks
Investors had plenty to keep them jittery in 2011. There were the earthquake and tsunami in Japan, economic woes in Europe, and, here at home, politically tinged fiscal showdowns in Washington over deep government spending cuts.
Still, the stock market...Tags: Stock Market, United Therapeutics Corp., Ben Bernanke, Japan Earthquake and Tsunami (2011), Investments
-
Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline
Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...Tags: Stock Market, Benlysta (drug), Science and Technology, Economy, Business and Finance, Food and Drug Administration
May 22, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
Oct 17, 2012
|Story| Baltimore Sun
Sep 5, 2012
|Story| Baltimore Sun
Jul 16, 2012
|Story| Baltimore Sun
Jul 2, 2012
|Story| Los Angeles Times
Jun 8, 2012
|Story| Baltimore Sun
Apr 21, 2012
|Story| Baltimore Sun
Dec 31, 2011
|Story| Baltimore Sun
Apr 19, 2012
|Story| Baltimore Sun
Original site for Human Genome Sciences Inc. topic gallery.